» Articles » PMID: 26689549

Cell Nucleus-Targeting Zwitterionic Carbon Dots

Overview
Journal Sci Rep
Specialty Science
Date 2015 Dec 23
PMID 26689549
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

An innovative nucleus-targeting zwitterionic carbon dot (CD) vehicle has been developed for anticancer drug delivery and optical monitoring. The zwitterionic functional groups of the CDs introduced by a simple one-step synthesis using β-alanine as a passivating and zwitterionic ligand allow cytoplasmic uptake and subsequent nuclear translocation of the CDs. Moreover, multicolor fluorescence improves the accuracy of the CDs as an optical code. The CD-based drug delivery system constructed by non-covalent grafting of doxorubicin, exhibits superior antitumor efficacy owing to enhanced nuclear delivery in vitro and tumor accumulation in vivo, resulting in highly effective tumor growth inhibition. Since the zwitterionic CDs are highly biocompatible and effectively translocated into the nucleus, it provides a compelling solution to a multifunctional nanoparticle for substantially enhanced nuclear uptake of drugs and optical monitoring of translocation.

Citing Articles

Exosome isolation based on polyethylene glycol (PEG): a review.

Huang Q, Wang J, Ning H, Liu W, Han X Mol Cell Biochem. 2024; .

PMID: 39702782 DOI: 10.1007/s11010-024-05191-x.


Synthesis of nanohybrid consisting of taurine derived carbon dots and nanoceria for anticancer applications.

Das J, Singh T, Lalruatsangi R, Sil P Toxicol Rep. 2024; 13:101794.

PMID: 39554612 PMC: 11568780. DOI: 10.1016/j.toxrep.2024.101794.


Anticancer activity of quantum size carbon dots: opportunities and challenges.

Bhattacharya T, Preetam S, Mukherjee S, Kar S, Roy D, Singh H Discov Nano. 2024; 19(1):122.

PMID: 39103694 PMC: 11300426. DOI: 10.1186/s11671-024-04069-7.


Targeting the organelle for radiosensitization in cancer radiotherapy.

Sun X, Wu L, Du L, Xu W, Han M Asian J Pharm Sci. 2024; 19(2):100903.

PMID: 38590796 PMC: 10999375. DOI: 10.1016/j.ajps.2024.100903.


Synthetic routes to theranostic applications of carbon-based quantum dots.

Gowtham P, Harini K, Thirumalai A, Pallavi P, Girigoswami K, Girigoswami A ADMET DMPK. 2023; 11(4):457-485.

PMID: 37937240 PMC: 10626517. DOI: 10.5599/admet.1747.


References
1.
Oyelere A, Chen P, Huang X, El-Sayed I, El-Sayed M . Peptide-conjugated gold nanorods for nuclear targeting. Bioconjug Chem. 2007; 18(5):1490-7. DOI: 10.1021/bc070132i. View

2.
Kim J, Urban K, Cochran E, Lee S, Ang A, Rice B . Non-invasive detection of a small number of bioluminescent cancer cells in vivo. PLoS One. 2010; 5(2):e9364. PMC: 2826408. DOI: 10.1371/journal.pone.0009364. View

3.
Mehiri M, Jing B, Ringhoff D, Janout V, Cassimeris L, Regen S . Cellular entry and nuclear targeting by a highly anionic molecular umbrella. Bioconjug Chem. 2008; 19(8):1510-3. PMC: 2711778. DOI: 10.1021/bc8001826. View

4.
Jana A, Saha B, Banerjee D, Ghosh S, Nguyen K, Ma X . Photocontrolled nuclear-targeted drug delivery by single component photoresponsive fluorescent organic nanoparticles of acridin-9-methanol. Bioconjug Chem. 2013; 24(11):1828-39. DOI: 10.1021/bc400170r. View

5.
Huang X, Zhang F, Zhu L, Choi K, Guo N, Guo J . Effect of injection routes on the biodistribution, clearance, and tumor uptake of carbon dots. ACS Nano. 2013; 7(7):5684-93. PMC: 3725601. DOI: 10.1021/nn401911k. View